CSF biopterin levels and clinical features of patients with juvenile parkinsonism.
Furukawa
Y
Y
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Nishi
K
K
Kondo
T
T
Mizuno
Y
Y
Narabayashi
H
H
D000328:Adult; D001708:Biopterins / Q000031:analogs & derivatives / Q000134:cerebrospinal fluid*; D004305:Dose-Response Relationship, Drug; D004421:Dystonia / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D019798:Neopterin; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D010302:Parkinson Disease, Secondary / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D012307:Risk Factors; D013787:Thalamic Nuclei / Q000187:drug effects / Q000601:surgery
D001708:Biopterins; D007980:Levodopa; D019798:Neopterin